Advanced Cell Technology Senior Scientist Dr. Robert Lanza Awarded for Outstanding Contributions to Biology by Brown University Biotech Group
Feb 2 2007, 7:33 AM EST
Business Wire
Advanced Cell Technology, Inc. (OTCBB:ACTC), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, has announced that Dr. Robert Lanza, the Company's Vice President of Research and Scientific Development, has been recognized for his groundbreaking research and contributions in stem cell science and biology with a special award from Brown University's Biotechnology Interest Group.
The Brown University biotech group made the award for "Outstanding Contribution in Contemporary Biology" to Dr. Lanza at the organization's 5th Annual Biotech Expo, held February 1, 2007, at Brown's Providence, R.I., campus. Dr. Lanza also delivered a keynote address at the conference.
Dr. Lanza is a noted pioneer in the field of stem cell science, with more than 25 years' experience in the application of stem cells in regenerative medicine. He has published several hundred papers, patents and innovations relating to stem cell science, among them ACTC's Single Cell Blastomere method to derive human embryonic stem cells without harming the donor embryos' potential for life.
"This award helps bring additional notice to the stem cell industry at a point when the field is entering an exciting period of clinical development," said Dr. Lanza. "At ACTC and at institutions around the world, we are focused on the development of powerful new products that have the potential to revolutionize treatment for a growing number of serious diseases and injuries."
